secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2024-08-01T23:59:59+00:00
Accession:  0001493152-24-029868
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa raises ~$830k via warrant inducement at $3.46; issues 200% new warrants
-------------------------------------------------------------------------------

- Holder exercises existing Series A/B warrants at reduced price $3.46 (from $12.50), gross proceeds ~$830k.
- New Series A-1 warrants for 392k shares (5-yr term) and Series B-1 for 86.6k shares (18-mo term), all at $3.46.
- New warrant shares subject to stockholder approval; meeting to be held within 90 days of closing.
- Engaged A.G.P./Alliance Global Partners as financial advisor for $50k cash fee.
- Company to file resale registration statement for new warrant shares by September 2, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315224029868/0001493152-24-029868-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315224029868/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-029868

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer